{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:06:04Z","timestamp":1788930364459,"version":"build-2803163510"},"reference-count":12,"publisher":"American Academy of Pediatrics (AAP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Evaluate the implementation of a pharmacist-managed opioid weaning regimen and objective opioid withdrawal assessment tool in pediatric patients requiring an opioid wean. We hypothesized that this combination would be associated with a reduction in the wean duration and length of stay and decrease episodes of opioid withdrawal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Retrospective cohort study utilizing pediatric inpatients requiring an inpatient opioid medication wean. The study was conducted in 3 phases from chart review of patients admitted from 2012 to 2020: baseline preintervention (phase 1), pharmacist-managed weaning regimen (phase 2), and addition of an objective assessment tool, the Withdrawal Assessment Tool-1 (phase 3). Data collection included the total wean duration, total duration of hospital admission, and number of episodes of opioid withdrawal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The study included 115 patients with 36 patients in phases 1 and 3 and 43 patients in phase 2. Median age ranged from 0.46 to 0.84 years and the majority of children were males. No significant differences in patient characteristics such as age, weight, sex, and previous opioid exposure were found between phases. Length of stay, wean duration, and episodes of withdrawal with need for rescue dose all decreased significantly from phase 1 to phase 3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Use of a pharmacist-managed weaning regimen combined with the Withdrawal Assessment Tool-1 tool was associated with significantly shorter methadone weans and overall length of stay. This has implications for wide spread dissemination and standardization of this approach in tertiary care children\u2019s hospitals caring for patients after ICU admission.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2021-006306","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T08:11:36Z","timestamp":1664871096000},"page":"945-953","source":"Crossref","is-referenced-by-count":7,"title":["Implementation of an Opioid Weaning Protocol at a Tertiary Care Children\u2019s Hospital"],"prefix":"10.1542","volume":"12","author":[{"given":"Jenna","family":"Ford","sequence":"first","affiliation":[{"name":"aOSF HealthCare Children\u2019s Hospital of Illinois, Peoria, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Harthan","sequence":"additional","affiliation":[{"name":"aOSF HealthCare Children\u2019s Hospital of Illinois, Peoria, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"McGarvey","sequence":"additional","affiliation":[{"name":"aOSF HealthCare Children\u2019s Hospital of Illinois, Peoria, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Mischler","sequence":"additional","affiliation":[{"name":"bUniversity of Illinois College of Medicine at Peoria, Peoria, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"issue":"1","key":"2023112014511399000_b1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pain.2011.10.003","article-title":"Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients","volume":"153","author":"Franck","year":"2012","journal-title":"Pain"},{"issue":"6","key":"2023112014511399000_b2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PCC.0b013e31818c8328","article-title":"The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients","volume":"9","author":"Franck","year":"2008","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"2023112014511399000_b3","first-page":"12","article-title":"Use of methadone for prevention of opioid withdrawal in critically ill children","volume":"65","author":"Jeffries","year":"2012","journal-title":"Can J Hosp Pharm"},{"issue":"5","key":"2023112014511399000_b4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003246-199405000-00009","article-title":"Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion","volume":"22","author":"Katz","year":"1994","journal-title":"Crit Care Med"},{"issue":"3","key":"2023112014511399000_b5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PCC.0000000000000048","article-title":"Evaluation of a pharmacist-managed methadone taper","volume":"15","author":"Steineck","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2023112014511399000_b6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1213\/01.ane.0000202395.94542.3e","article-title":"A prospective evaluation of opioid weaning in opioid-dependent pediatric critical care patients","volume":"102","author":"Berens","year":"2006","journal-title":"Anesth Analg"},{"issue":"2","key":"2023112014511399000_b7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00130478-200010000-00005","article-title":"Evaluation of an opiate-weaning protocol using methadone in pediatric intensive care unit patients","volume":"1","author":"Robertson","year":"2000","journal-title":"Pediatr Crit Care Med"},{"issue":"11","key":"2023112014511399000_b8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/PCC.0000000000001719","article-title":"Implementation of risk-stratified opioid and benzodiazepine weaning protocol in a pediatric cardiac ICU","volume":"19","author":"Amirnovin","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2023112014511399000_b9","first-page":"165","article-title":"Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol","volume":"19","author":"Johnson","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"12","key":"2023112014511399000_b10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40265-020-01338-4","article-title":"Strategies for the prevention and treatment of iatrogenic withdrawal from opioids and benzodiazepines in critically ill neonates, children, and adults: A systematic review of clinical studies","volume":"80","author":"Sneyers","year":"2020","journal-title":"Drugs"},{"issue":"6","key":"2023112014511399000_b11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.iccn.2004.07.008","article-title":"Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients","volume":"20","author":"Franck","year":"2004","journal-title":"Intensive Crit Care Nurs"},{"issue":"8","key":"2023112014511399000_b12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PCC.0b013e31829f5be1","article-title":"Psychometric evaluation of the Sophia Observation withdrawal symptoms scale in critically ill children","volume":"14","author":"Ista","year":"2013","journal-title":"Pediatr Crit Care Med"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/11\/945\/1573806\/hpeds.2021-006306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/11\/945\/1573806\/hpeds.2021-006306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:55:34Z","timestamp":1700492134000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/12\/11\/945\/189662\/Implementation-of-an-Opioid-Weaning-Protocol-at-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":12,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,10,4]]},"published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-006306","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]}}}